Antioxidant enzymes and cancer

Chinese Journal of Cancer Research

Volumn 22, Issue 2, 2010, Pages 87-92

  Khan, Md Asaduzzaman ^a   Tania, Mousumi ^a   Zhang, Dian Zheng ^a,b   Chen, Han Chun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

Cancer; Catalase; Glutathione peroxidase; Glutathione S Transferase; Superoxide dismutase

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; OXIDOREDUCTASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SUPEROXIDE DISMUTASE; TAURINE;

ANTIOXIDANT ACTIVITY; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CD8+ T LYMPHOCYTE; COLORECTAL CANCER; DISEASE ASSOCIATION; DNA DAMAGE; ENZYME POLYMORPHISM; HUMAN; LARYNX CARCINOMA; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW;

EID: 77954664665     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-010-0087-7     Document Type: Review

References (58)

1. Champe PC, Harvey RA, Ferrier DR. Intermediary metabolism. Champe PC, Lippincott's Illustrated Reviews: Biochemistry. 4th edition[M]. Lippincott Williams & Wilkins. Philadelphia, USA. 2007; p: 69-82, 148.
2. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease[J]. Int J Biochem Cell Biol 2007; 39: 44-84.
3. Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research[J]. J Nutr 2003; 133: 933S-40S.
4. Bagchi K, Puri S. Free radicals and antioxidants in health and disease[J]. Eastern Mediterranean Health Journal 1998; 4: 350-360
5. Frederiks WM, Bosch KS, Hoeben KA, et al. Renal cell carcinoma and oxidative stress: The lack of peroxisomes[J]. Acta Histochem 2009; Jun 3 [Epub ahead of print]
6. Hussain SP, Raja K, Amstad PA, et al. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases[J]. Proc Natl Acad Sci USA 2000; 97: 12770-12775
7. Gargouri B, Lassoued S, Ayadi W, et al. Lipid peroxidation and antioxidant system in the tumor and in the blood of patients with nasopharyngeal carcinoma[J]. Biol Trace Elem Res 2009; 132: 27-34.
8. Kulbacka J, Saczko J, Chwilkowska A. Oxidative stress in cells damage processes[J]. Pol Merkur Lekarski 2009; 27: 44-47
9. Sengottuvelan M, Deeptha K, Nalini N. Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis[J]. Chem Biol Interact 2009; 181: 193-201.
10. Elchuri S, Oberley TD, Qi W, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life[J]. Oncogene 2005; 24: 367-380
11. Plymate SR, Haugk KH, Sprenger CC, et al. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-proteinrelated protein-1[J]. Oncogene 2003; 22: 1024-1034
12. Aggarwal S, Subberwal M, Kumar S, et al. Brain tumor and role of beta-carotene, a-tocopherol, superoxide dismutase and glutathione peroxidases[J]. J Cancer Res Ther 2006; 2: 24-27
13. de Haan JB, Cristiano F, Iannello R, et al. Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide[J]. Hum Mol Genet 1996; 5: 283-292
14. Chung-man Ho J, Zheng S, Comhair SA, et al. Differential expression of manganese superoxide dismutase and catalase in lung cancer[J]. Cancer Res 2001; 61: 8578-8585
15. Okada F, Shionoya H, Kobayashi M. Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase[J]. Br J Cancer 2006; 94: 854-862
16. Er TK, Hou MF, Tsa EM, et al. Differential expression of manganese containing superoxide dismutase in patients with breast cancer in taiwan[J]. Ann Clin Lab Sci 2004; 34: 159-164
17. Kacakci A, Aslan I, Toplan S, et al. Significance of the counteracting oxidative and antioxidative systems in the pathogenesis of laryngeal carcinoma[J]. J Otolaryngol Head Neck Surg 2009; 38: 172-177
18. Mason EE, Chin TF, Li YW, et al. Cancer and human liver catalase[J]. Cancer Res 1960; 20: 1474-1481
19. Falkson G, Dejager ME. Catalase activity in the epidermis of patients with advanced cancer[J]. Nature 1964; 202: 203-204
20. De Craemer D, Pauwels M, Hautekeete M, et al. Alterations of hepatocellular peroxisomes in patients with cancer. Catalase cytochemistry and morphometry [J]. Cancer 1993; 71: 3851-3858
21. Surapaneni KM, Sadagopan C. Status of Lipid peroxidation and antioxidant enzymes in patients with carcinoma of breast[J]. J Med Sci Res 2007; 1: 21-24
22. Ahn J, Gammon MD, Santella RM, et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use[J]. Am J Epidemiol 2005; 162: 943-952
23. Yamamoto T, Sakaguchi N, Hachiya M, et al. Role of catalase in monocytic differentiation of U937 cells by TPA: hydrogen peroxide as a second messenger[J]. Leukemia 2009; 23: 761-769
24. Petit E, Courtin A, Kloosterboer HJ, et al. Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition[J]. J Steroid Biochem Mol Biol 2009; 115(3-5): 153-160
25. Mannervik B. The enzymes of glutathione metabolism: an overview[J]. Biochem Soc Trans 1987; 15: 717-718
26. Meister A. Glutathione metabolism and its selective modification[J]. J Biol Chem 1988; 263: 17205-17208
27. Moscow JA, Schmidt L, Ingram DT, et al. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer[J]. Carcinogenesis 1994; 15: 2769-2773
28. Ratnasinghe D, Tangrea JA, Andersen MR, et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk[J]. Cancer Res 2000; 60: 6381-6383
29. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer loss of heterozygosity and allelic differences in the response to selenium[J]. Cancer Res 2003; 63: 3347-3351.
30. Moscow JA, Morrow CS, He R, et al. Structure and function of the 5'-flanking sequence of the human cytosolic selenium-dependent glutathione peroxidase gene (hgpx1)[J]. J Biol Chem 1992; 267: 5949-5958
31. Chada S, Whitney C, Newburger PE. Posttranscriptional regulation of glutathione peroxidase gene expression by selenium in the HL-60 human myeloid cell line[J]. Blood 1989; 74: 2535-2541
32. Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum selenium and risk of cancer[J]. Lancet 1983; 2: 130-134
33. Comstock GW, Alberg AJ, Huang HY, et al. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity[J]. Cancer Epidemiol Biomarkers Prev 1997; 6: 907-916
34. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer[J]. J Natl Cancer Inst 1998; 90: 1219-1224
35. Brooks JD, Metter EJ, Chan DW, et al. Plasma selenium level before diagnosis and the risk of prostate cancer development[J]. J Urol 2001; 166: 2034-2038
36. Leaver MJ, George SG. A piscine glutathione S-transferase which efficiently conjugates the end-products of lipid peroxidation[J]. Marine Environ Res 1998; 46: 71-74
37. Houlstone RS. Glutathione S-transferase M1 status and lung cancer risk: A meta-analysis[J]. Cancer Epidemiol Biomark Prev 1999; 8: 675-682
38. Ambrosone CB, Coles BF, Freudenheim JL, et al. Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants[J]. J Nutr 1999; 129: 565S-8S.
39. Curran JE, Weinstein SR, Griffiths LR. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility[J]. Cancer Lett 2000; 153: 113-120
40. Smith RA, Curran JE, Weinstein SR, et al. Investigation of glutathione S-transferase zeta and the development of sporadic breast cancer[J]. Breast Cancer Res 2001; 3: 409-411
41. Park SK, Yoo KY, Lee SJ, et al. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk[J]. Pharmacogenetics 2000; 10: 301-309
42. Mao GE, Morris G, Lu QY, et al. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer[J]. Cancer Detect Prev 2004; 28: 368-374
43. Nomani H, Ghobadloo SM, Yaghmaei B, et al. Glutathione S-transferases activity in patients with colorectal cancer[J]. Clin Biochem 2005; 38: 621-624
44. Prabhu K, Bhat GP. Serum total glutathione-Stransferase levels in oral cancer[J]. J Cancer Res Ther 2007; 3: 167-168
45. Sharma A, Tripathi M, Satyam A, et al. Study of antioxidant levels in patients with multiple myeloma[J]. Leuk Lymphoma 2009; 50: 809-815
46. Ho JC, Chan-Yeung M, Ho SP, et al. Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma[J]. Eur Respir J 2007; 29: 273-278
47. Monari M, Foschi J, Calabrese C, et al. Implications of antioxidant enzymes in human gastric neoplasms[J]. Int J Mol Med 2009; 24: 693-700.
48. Arsova-Sarafinovska Z, Eken A, Matevska N, et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer[J]. Clin Biochem 2009; 42: 1228-1235
49. Kotrikadze N, Alibegashvili M, Zibzibadze M, et al. Activity and content of antioxidant enzymes in prostate tumors[J]. Exp Oncol 2008; 30: 244-247
50. Gokul S, Patil V, Jailkhani R, et al. Oxidantantioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients[J]. Oral Dis 2009; Jul 27 [Epub ahead of print].
51. Rajaraman P, Hutchinson A, Rothman N, et al. Oxidative response gene polymorphisms and risk of adult brain tumors[J]. Neuro Oncol 2008; 10: 709-715
52. Battisti V, Maders LD, Bagatini MD, et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients[J]. Clin Biochem 2008; 41: 511-518
53. Jeon SH, Park JH, Chang SG. Expression of antioxidant enzymes (catalase, superoxide dismutase, and glutathione peroxidase) in human bladder cancer[J]. Korean J Urol 2007; 48: 921-926
54. Onumah OE, Jules GE, Zhao Y, et al. Overexpression of catalase delays G0/G1- to S-phase transition during cell cycle progression in mouse aortic endothelial cells[J]. Free Radic Biol Med 2009, 46: 1658-1667
55. Ando T, Mimura K, Johansson CC, et al. Transduction with the antioxidant enzyme catalase protects human t cells against oxidative stress[J]. J Immunol 2008; 181: 8382-8390
56. Liu J, Hinkhouse MM, Sun W, et al. Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype[J]. Hum Gene Ther 2004; 15: 239-250
57. Yu J, Kim AK. Effect of taurine on antioxidant enzyme system in B16F10 melanoma cells[J]. Adv Exp Med Biol 2009; 643: 491-499
58. Feng X, Zhang L, Zhu H. Comparative anticancer and antioxidant activities of different ingredients of Ginkgo biloba extract (EGb 761)[J]. Planta Med 2009; 75: 792-796